Position in REGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$161,694,522
-$109,442,624 QoQ
Shares Held
259,317
-26.1% QoQ
Ownership
0.252%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#51
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. REGN ranks #1 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $161,694,522 | 259,317 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $271,137,146 | 350,923 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $306,858,462 | 397,552 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $210,437,419 | 374,264 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $169,499,925 | 322,857 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $223,177,291 | 351,887 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $256,003,565 | 359,389 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $346,979,632 | 330,067 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $369,484,341 | 351,545 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $259,401,642 | 269,511 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $90,036,142 | 102,513 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $148,352,530 | 180,267 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $78,780,007 | 109,639 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $92,137,143 | 112,134 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $74,071,770 | 102,665 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $63,611,633 | 92,342 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $51,602,102 | 87,294 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $56,878,626 | 81,439 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $51,558,555 | 81,642 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $48,419,241 | 80,008 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $45,123,329 | 80,788 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $37,228,547 | 78,684 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $36,647,758 | 75,858 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $41,822,283 | 74,712 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $43,314,987 | 69,454 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $29,865,769 | 61,164 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||